We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Barr Launches Generic Seasonale to Defend Market as it Awaits Patent Reissue
Barr Launches Generic Seasonale to Defend Market as it Awaits Patent Reissue
September 19, 2006
Barr Pharmaceuticals, faced with generic competition to its birth-control drug Seasonale after an unsuccessful attempt for a patent reissue, launched an authorized generic Sept. 7 — the day Watson Pharmaceuticals received final FDA approval to market its version.